Cargando…
Apolipoprotein A5 alleviates LPS/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway
BACKGROUND: Fulminant liver failure (FHF) is a serious clinical problem and liver transplantation is the major intervention. But the overall survival rate of FHF is low owing to the donated organ shortage. Apolipoprotein A-V (ApoA5) is a regulator of triglyceride metabolism and has been reported to...
Autores principales: | Tao, Ya-Chao, Wang, Meng-Lan, Wu, Dong-Bo, Luo, Chen, Tang, Hong, Chen, En-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511152/ https://www.ncbi.nlm.nih.gov/pubmed/31077206 http://dx.doi.org/10.1186/s12967-019-1900-9 |
Ejemplares similares
-
Complement and the Alternative Pathway Play an Important Role in LPS/D-GalN-Induced Fulminant Hepatic Failure
por: Sun, Shihui, et al.
Publicado: (2011) -
Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway
por: Zhou, Ziyuan, et al.
Publicado: (2023) -
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome
por: Liu, Yimei, et al.
Publicado: (2022) -
Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury via the TLR4/NF-κB Pathway
por: Qu, Xiao-qin, et al.
Publicado: (2022) -
UMSCs Attenuate LPS/D-GalN-induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway
por: Liao, Hailing, et al.
Publicado: (2021)